Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacological Research|August 16, 2015
Mitochondrial ROS and cancer drug resistance: Implications for therapyImoh S Okon, Ming-Hui Zou
The Journal of Biological Chemistry|November 29, 2013
Liver kinase B1 expression promotes phosphatase activity and abrogation of receptor tyrosine kinase phosphorylation in human cancer cellsImoh S Okon, Kathleen A Coughlan, Ming-Hui Zou
The Journal of Biological Chemistry|February 15, 2015
Gefitinib-mediated reactive oxygen specie (ROS) instigates mitochondrial dysfunction and drug resistance in lung cancer cellsImoh S Okon, Kathleen A Coughlan, Miao Zhang, et al.
Oncotarget|December 25, 2015
Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancersImoh S Okon, Ye Ding, Kathleen A Coughlan, et al.
The Journal of Clinical Investigation|September 3, 2014
Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit angiogenesisImoh S Okon, Kathleen A Coughlan, Cheng Zhang, et al.
Molecular Cancer Therapeutics|August 5, 2017
The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast CancerElisa Zanini, Louay S Louis, Jane Antony, et al.
Cancer Discovery|May 16, 2012
The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancerArthur B McKie, Sebastian Vaughan, Elisa Zanini, et al.
Pageof 1